Hematology Oncology Medical Affairs Interns (Undergraduate)
We are looking for Undergraduate students majoring in Biology, Biochemistry, Chemistry, Physics, Information Technology, or a related field for a 12-week internship role in Gaithersburg, MD from May 18 2026 to August 7 2026.
Position Description:
- The role will be placed on one of 4 teams within the Hematology division: Leukemia Team, Lymphoma Team, Myeloma Team, and Field-Support Team.
- Duties will be as follows:
- Analyzing data-sets from real-world evidence databases and registries
- Producing summary reports of key meetings such as advisory boards
- Organization support of day-to-day US Medical Affairs organization activities
Position Requirements:
- Undergraduate students majoring in Biology, Biochemistry, Chemistry, Physics, Information Technology, or a related field.
- Candidates must have an expected graduation date after August 2026.
- Coding skills such as Python or Java are a plus
- Power BI or other dashboard management experience is a plus
- Statistical analysis experience is a plus
- Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design.
- Understanding of MS Office Suite (Excel, Word, PowerPoint) is required.
- US Work Authorization is required at time of application.
- This role will not be providing CPT support.
- Ability to report onsite to Gaithersburg, MD (Rio Complex) 3-5 days per week. This role will not provide relocation assistance.
- Compensation range: $37-39 per hour
Date Posted
03-Dec-2025Closing Date
30-Dec-2025Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Join our Talent Network
Be the first to receive job updates and news from AstraZeneca
Sign up